Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents

被引:24
|
作者
Choi, Ji-Seon [1 ]
Park, Ikchun [1 ]
Lee, Soo Jung [2 ]
Ju, Hyo Jin [3 ]
Lee, Hyeyoung [1 ]
Kim, Jayoung [1 ]
机构
[1] Catholic Kwandong Univ, Int St Marys Hosp, Dept Lab Med, Coll Med, 25 Simgok Ro 100Beon-gil, Incheon 22711, South Korea
[2] Catholic Kwandong Univ, Int St Marys Hosp, Dept Pediat, Coll Med, Incheon, South Korea
[3] Catholic Kwandong Univ, Dept Med Humanities, Coll Med, Incheon, South Korea
关键词
Children; adolescent; P1NP; osteocalcin; bone marker; BONE TURNOVER MARKERS; REFERENCE INTERVALS; BIOCHEMICAL MARKERS; COLLAGEN; ASSAY;
D O I
10.3349/ymj.2019.60.12.1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Bone markers can be useful for the diagnosis and treatment of skeletal diseases in children and adolescents. Owing to high skeletal growth velocity and rapid bone turnover, children and adolescents have higher bone marker levels than adults. Thus, a valid age- and sex-specific reference should be established for pediatric populations living in similar environments. We aimed to assess the associations of procollagen type I N-terminal propeptide (P1NP) and osteocalcin with age and sex in a group of healthy Korean children and adolescents. Materials and Methods: The participants (290 boys and 290 girls, age range 0-18 years) were Korean outpatients. Serum P1NP and osteocalcin levels were measured in control materials and patient samples by electrochemiluminescence immunoassay using an automated Cobas e411 analyzer. Results: Significant age-dependent variations in bone marker levels were observed in both sexes (p<0.001). 'the highest P1NP levels were observed during the first year of life; thereafter, levels decreased. until puberty. There was no postnatal peak for osteocalcin; however, its levels remained higher than the adult reference range throughout childhood. Significant differences were observed between boys and girls (p<0.05), especially between the ages of 12 and 17 years. Cobas e411 results for P1NP showed satisfactory precision and linearity. Conclusion: We established reference data for P1NP and osteocalcin levels in healthy Korean children and adolescents, as the first and only study of these parameters in pm-adulthood in Korea. Cobas e411-quantified bone markers may be useful for determining bone metabolism indices.
引用
收藏
页码:1174 / 1180
页数:7
相关论文
共 50 条
  • [31] Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease
    Mosca, Antonella
    Mantovani, Alessandro
    Crudele, Annalisa
    Panera, Nadia
    Comparcola, Donatella
    De Vito, Rita
    Bianchi, Marzia
    Byrne, Christopher D.
    Targher, Giovanni
    Alisi, Anna
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [32] PURIFICATION OF HUMAN PROCOLLAGEN TYPE-I CARBOXYL-TERMINAL PROPEPTIDE CLEAVED AS IN-VIVO FROM PROCOLLAGEN AND USED TO CALIBRATE A RADIOIMMUNOASSAY OF THE PROPEPTIDE
    PEDERSEN, BJ
    BONDE, M
    CLINICAL CHEMISTRY, 1994, 40 (05) : 811 - 816
  • [33] Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients
    López, B
    Querejeta, R
    Varo, N
    González, A
    Larman, M
    Ubago, JLM
    Díez, J
    CIRCULATION, 2001, 104 (03) : 286 - 291
  • [34] PROCOLLAGEN III N-TERMINAL PROPEPTIDE BEYOND A FIBROSIS BIOMARKER IN NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH OBESITY IN CHILDREN
    Rangel, O.
    Aguiar-Santana, I.
    Mata, C.
    Gil-Campos, M.
    Canete, R.
    Gil, A.
    Aguilera, C.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 236 - 236
  • [35] Circulating carboxy-terminal propeptide of type I procollagen is increased in rheumatic heart disease
    Banerjee, Tanima
    Mukherjee, Somaditya
    Biswas, Monodeep
    Dutta, Santanu
    Chatterjee, Shelly
    Ghosh, Sudip
    Pattari, Sanjib
    Nanda, Navin C.
    Bandyopadhyay, Arun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (01) : 117 - 119
  • [36] Changes of procollagen type III N-terminal propeptide (PIIINP) concentrations during healing of mandible fractures treated with biodegradable and titanium fixations
    Borys, J.
    Antonowicz, B.
    Grabowska, S. Z.
    ADVANCES IN MEDICAL SCIENCES, 2013, 58 (02): : 434 - 441
  • [37] Serum N-terminal telopeptide of type I collagen as an early marker of fracture nonunion in rabbits
    Lin, Jian-Ping
    Shi, Zhan-Jun
    Shen, Ning-Jiang
    Wang, Jian
    Li, Zao-Min
    Xiao, Jun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3595 - 3601
  • [38] Association between serum cytokeratin 18 and N-terminal procollagen III propeptide in patients with biopsy-proven nonalcoholic fatty liver disease
    Kaya, Sercan
    Boydak, Murat
    Aydin, Mesut
    Aras, Ibrahim
    BIOTECHNIC & HISTOCHEMISTRY, 2024, 99 (06) : 313 - 319
  • [39] Heritability assessment of cartilage metabolism. A twin study on circulating procollagen IIA N-terminal propeptide (PIIANP)
    Munk, H. L.
    Svendsen, A. J.
    Hjelmborg, J. V. B.
    Sorensen, G. L.
    Kyvik, K. O.
    Junker, P.
    OSTEOARTHRITIS AND CARTILAGE, 2014, 22 (08) : 1142 - 1147
  • [40] Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation
    Yamamoto, Takanori
    Tsujimoto, Mika
    Sowa, Hideaki
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 1101 - 1109